UltraTech Cement
- P/E
- 36.8x
- 52-week range
- 10,325 – 13,110
- ROE
- 11%
- ROCE
- 13%
- Sector
- Cement & Cement Products
- Industry
- Cement & Cement Products
- Listed on
- NSE, BSE
About
UltraTech Cement Limited is an India-based company, which is engaged in the business of manufacturing and sale of cement and cement related products. The Company’s products include UltraTech Cement, Ready Mix Concrete, Building Solutions, and Building Products. Its UltraTech Cement products include Ordinary Portland Cement (OPC), Portland Pozzolana Cement (PPC), and Portland Slag Cement. Its Building Solutions products include cement, steels, painting system, waterproofing and chemicals, electricals, plywood, shuttering ply, power and hand tools, flooring, pipes, sanitary ware, mortars, roofing, and water storage tanks. Its Building Products include Tiles Adhesives (TILEFIXO-CT, TILEFIXO-VT, TILEFIXO-NT, and TILEFIXO-YT), Repair Products (MICROKRETE and BASEKRETE), Waterproofing Products (SEAL & DRY, FLEX, HIFLEX, and MYKROFILL), Industrial and Precision Grout (POWERGROUT NS1, NS2, and NS3), Masonry Products (FIXOBLOCK), and Light Weight Autoclaved Aerated Concrete Block (XTRALITE).
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Cement & Cement Products: 42 companies →UltraTech Cement against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)36.8 against a typical 30: pricier than most peers (1st = cheapest).24th of 40
- Sales growth+18.8% against a typical +9.4% from a year earlier.12th of 37
- Profit growth+21.2% against a typical −31.3% from a year earlier.5th of 28
- Share price, 3 months−7.5% against a typical −13.2%.12th of 39
Latest announcements
Exchange filings and their impact on the company.
- 27 Oct 2026Analysts/Institutional Investor Meet/Con. Call UpdatesMedium impactPositivePrice −0.3% that dayStrong volumes and 5% exit price rise set up double-digit growth with margin recovery despite fuel spike.
UltraTech's Q2 FY27 earnings call said cement volumes grew 13.8% with 71% utilisation, ahead of ~10% industry growth, while trade prices exited September about 3% above Q1 and spot realisations are about 5% above the Q2 average. Fuel cost rose from Rs45 to Rs51.5 per bag to Rs2.09-2.2 per kcal on the West Asia crisis and petcoke at $180, but fixed cost per ton fell 6%. The company commissioned 4.6MT to reach 204.7MT domestic capacity, guided Rs10,000 crore FY capex with net debt to EBITDA at 1.26x falling below 1x by March, and launched Ultravolt wires with 80,000 retail points.
- Strong Q2 with 13% volume and 21% profit growth plus a 46 mtpa expansion pipeline points to double-digit growth ahead.
UltraTech reported a strong Q2FY27 with revenue of Rs 23,024 crore up 18.9%, sales volume of 38.2 million tonnes up 12.9%, operating EBITDA of Rs 3,721 crore up 20.3% and net profit of Rs 1,501 crore up 21.3%. Capacity rose to 210.1 mtpa after 4.6 mtpa was commissioned, utilisation improved to 71%, and green power reached 46.4% of power mix. The company laid out plans to add 16.3 mtpa in FY27 and 29.8 mtpa in FY28 to reach 242.9 mtpa, alongside growth in ready-mix, chemicals and the newly launched Ultravolt wires business.
- Strong Q2 with 19% sales and 21% PAT growth plus 4.6 mtpa new capacity supports double-digit earnings growth.
UltraTech reported strong Q2 FY27 results with net sales up 18.9% to Rs 23,024 crore and PAT up 21.3% to Rs 1,501 crore, as domestic cement volumes rose 13.8% to 35.94 million tonnes and utilisation improved to 71%. It commissioned 3.6 mtpa greenfield capacity at Petnikota plus 1.0 mtpa debottlenecking, taking global grey cement capacity to 210.1 mtpa, and launched its Ultravolt wires and cables business with a new Jhagadia plant. The momentum from volumes and ongoing expansion toward 240+ mtpa by March 2028 supports continued growth, though margins were flat and borrowings rose to fund capex.
- Board approved USD 55mn guarantee for associate loan, adding small contingent liability.
UltraTech Cement's board on 19 October 2026 approved a corporate guarantee of up to USD 55 million for a loan to be taken by UHG Holdings IFSC Private Limited, an associate company. At current exchange rates this is about Rs 480-490 crore of contingent liability. The guarantee does not immediately affect revenue or profit and is small against UltraTech's Rs 88,512 crore revenue and Rs 23,755 crore borrowings.
- UltraTech MD K.C. Jhanwar to become Non-Executive Vice Chairman from Jan 2027 as K.K. Maheshwari steps down.
UltraTech Cement said K.K. Maheshwari will relinquish his role as Non-Executive Vice Chairman from 1st January 2027 due to other engagements. Managing Director Kailash Chandra Jhanwar, whose term ends on 31st December 2026, will be re-designated as Non-Executive Vice Chairman from the same date. No new Managing Director was announced; the move ensures leadership continuity with no change to operations.
- UltraTech announces planned Vice Chairman rotation as MD's term ends in December.
UltraTech Cement said K. K. Maheshwari will relinquish his position as Non-Executive Vice Chairman effective 1st January 2027 due to other engagements. Managing Director Kailash Chandra Jhanwar will complete his term on 31st December 2026 and has been re-designated as Non-Executive Vice Chairman from 1st January 2027. The changes were approved by the Board on 19th October 2026, indicating a planned leadership transition with continuity.
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
Highest safety
Rated AAA by 2 agencies- All agencies agree and none has raised a warning.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CRISIL | Crisil AAA | Stable | 17 Aug 2026 |
| CARE | CARE AAA | Stable | 23 Jul 2026 |
| India Ratings | Withdrawn | Stable | 19 Feb 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 17 Aug 2026 | Reaffirmed | Crisil AAA | — | CRISIL | ₹ 19,500 Cr. | |
| 23 Jul 2026 | Reaffirmed | CARE AAA / CARE A1+ → CARE AAA | — | CARE | ₹ 22,100 Cr. | |
| 23 Jul 2026 | Reaffirmed | Crisil AAA | — | CRISIL | ₹ 19,250 Cr. | |
| 24 Jun 2026 | Reaffirmed | CARE AAA / CARE A1+ | — | CARE | ₹ 17,100 Cr. | |
| 19 Feb 2026 | Withdrawn | was IND AAA | — | India Ratings | ₹ 21,410.9 Cr. |
Research by Minerva Capital Research Solutions
Our research team's work on UltraTech CementAlso covered in
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 19 Oct 2026 | Financial Results | To consider and approve the financial results for the period ended September 30, 2026 |
| 20 Jul 2026 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 |
| 27 Apr 2026 | Financial Results/Dividend | To consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the year ending 31st March, 2026 and recommend dividend, if any, on the equity shares of the Company for the year ending 31st March, 2026. |
| 24 Jan 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 18 Oct 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
| 21 Jul 2025 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2025 |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 16,740 | 20,419 | 18,819 | 16,294 | 17,779 | 23,063 | 21,275 | 19,607 | 21,830 | 25,799 | 24,648 | 23,295 |
| Expenses | 13,485 | 16,305 | 15,801 | 14,269 | 14,885 | 18,456 | 16,869 | 16,518 | 17,919 | 20,201 | 19,633 | 19,576 |
| Operating Profit | 3,255 | 4,114 | 3,017 | 2,026 | 2,893 | 4,608 | 4,406 | 3,089 | 3,911 | 5,599 | 5,015 | 3,719 |
| OPM % | 19% | 20% | 16% | 12% | 16% | 20% | 21% | 16% | 18% | 22% | 20% | 16% |
| Other Income | 146 | 73 | 83 | 226 | 247 | 93 | 142 | 174 | 46 | 77 | 118 | 105 |
| Interest | 262 | 261 | 326 | 393 | 457 | 475 | 433 | 459 | 492 | 487 | 453 | 552 |
| Depreciation | 783 | 815 | 918 | 980 | 993 | 1,125 | 1,107 | 1,148 | 1,182 | 1,208 | 1,201 | 1,213 |
| Profit before tax | 2,355 | 3,111 | 1,857 | 879 | 1,691 | 3,101 | 3,008 | 1,656 | 2,283 | 3,981 | 3,480 | 2,059 |
| Tax % | 25% | 27% | 20% | 19% | 19% | 20% | 26% | 25% | 24% | 25% | 25% | 27% |
| Net Profit | 1,775 | 2,259 | 1,493 | 708 | 1,363 | 2,475 | 2,221 | 1,238 | 1,729 | 3,000 | 2,604 | 1,501 |
| EPS in Rs | 61.55 | 78.22 | 51.78 | 24.34 | 47.09 | 84.23 | 75.54 | 41.79 | 58.55 | 101.22 | 88.21 | 50.69 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 13%
- 5 Years
- 15%
- 3 Years
- 12%
- TTM
- 17%
- 10 Years
- 13%
- 5 Years
- 8%
- 3 Years
- 17%
- TTM
- 21%
- 10 Years
- 11%
- 5 Years
- 9%
- 3 Years
- 10%
- TTM
- —
- 10 Years
- 11%
- 5 Years
- 11%
- 3 Years
- 11%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| UltraTech Cement | ₹ 11,104.00 | — | 36.8x | — | 11% | — |
| Grasim Industries | ₹ 2,898.00 | ₹ 1,95,975 Cr. | 40.8x | 2x | 4.9% | 5.9% |
| Ambuja Cements | ₹ 358.00 | ₹ 88,956 Cr. | 21.9x | 1.8x | 8.3% | 13.8% |
| Shree Cement | ₹ 22,760.00 | ₹ 82,120 Cr. | 55.2x | 4.1x | 7.8% | 8.4% |
| Dalmia Bharat | ₹ 1,591.65 | ₹ 29,801 Cr. | 29.5x | 1.9x | 6.5% | 7.8% |
| ACC | ₹ 1,163.00 | ₹ 21,851 Cr. | 12.3x | 1.3x | 10.9% | 8.3% |
Management
- Atul Daga
- Chief Financial Officer
- Vivek Agrawal
- Chief Marketing Officer, Whole-Time Director
- Dhiraj Kapoor
- Compliance Officer, Company Secretary
- Kailash Chandra Jhanwar
- Managing Director, Executive Director
- Jayant Dua
- Managing Director(Designate), Director
- Ashok Kumar P
- Chief Legal Officer
Prices are delayed and for information only. Nothing on this page is investment advice.